AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Breztri Aerosphere by Year
Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Established RoW YoY actual (%) (%)
AstraZeneca Breztri Aerosphere: 30.0% in FY2025, down 11.0 pts from a year earlier.
Latest, FY2025
30.0%
Period ended Dec 31, 2025
Change on a year earlier
-11.0 pts
41.0% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Breztri | 1,199 | 23 | 22 | 614 | 19 | 298 | 22 | 22 | 191 | 33 | 29 | 96 | 30 | 30”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Established RoW YoY actual (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30.0% | -11.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 41.0% | -14.0 pts | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 55.0% | +23.0 pts | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 32.0% | – | Form 6-K FY2022Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Breztri Aerosphere (%), annual FY2022–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-breztri-erow-act-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.